E-health: Patterns of use and perceived benefits and barriers among people living with HIV and their physicians, Part 2
mHealth apps and smart devices have failed to garner adoption by PLHIV. There is a case for good-quality health data sharing and exchange if PLHIV are provided with appropriately secure tools and physicians are backed up by adapted legislation.
E-health: Patterns of use and perceived benefits and barriers among people living with HIV and their physicians, Part 1
More than half of PLWH surveyed had already searched for health information on the Internet, and one in two had changed their behavior based on the online search. PLWH did not see the Internet as an alternative to physicians but they wanted their physicians to guide them on how to find quality health information to better self-manage their condition.
Maintaining HIV care during the COVID-19 pandemic
Weak healthcare systems have been exposed during the COVID-19 pandemic and challenges have arisen in regard to maintaining HIV care continuum during the COVID-19 pandemic. Particular efforts must focus on ensuring this care to avoid disruption of routine HIV services.
Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy
The study aimed to determine the relationship between oral and gut microbiome diversity and chronic systemic inflammation in ART-treated PLWH with prevalent severe periodontitis, an inflammatory condition commonly associated with HIV infection.
Geriatric syndromes in people living with HIV associated with aging and increasing comorbidities: implications for neurocognitive complications of HIV infection
Many aging people with HIV experience health effects similar to people who are 5-10 years older than them. This includes cognitive decline, something that is highly prevalent in older generations. Researchers look at the relationship between living with HIV and cognitive impairment. This article also addresses body composition changes in people with HIV and the clinical complications.
HIV and Aging in Mainland China: Implications for Control and Prevention
The last 15 years have witnessed a dramatic change in HIV-related epidemiology amidst improvements in treatment and care in China. With proper treatment, HIV is now considered a chronic disease. As a consequence, many people living with HIV (PLWH) now present age-related comorbidities. Thirteen topical issues were reviewed concerning the epidemiology of aging with HIV in mainland China.
Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men – 23 Urban Areas, 2017
A lower percentage of black and Hispanic men who have sex with men (MSM) than white MSM had discussed PrEP with a health care provider or had used PrEP within the past year. Healthcare provider training regarding cultural competencies may be beneficial when interacting with patients who are of these communities to ensure everyone gets equitable healthcare.
Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long-term suppressive antiretroviral therapy
This study evaluates the levels of systemic inflammation to better understand the risk of age-associated diseases in PLHIV on long-term suppressive ART using a large number of biomarkers of inflammation and immune activation. This study found that there is still a large amount of inflammation in those who are on ART as in those who were untreated.
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Co-morbidities and multi-morbidities are extremely prevalent in people living with HIV. More than 50% of PLHW were multi-morbid and about 30% had three or more comorbidities. Those living with HIV are much more at risk of dying or living with more than one disease.
Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy
The study looked at 16S rDNA-based pyrosequencing to compare the salivary microbiome in three groups: (1) Chronically HIV-infected women >50 years of age (aging); (2) HIV-infected women <35 years of age (young adult); and (3) HIV-uninfected age-matched women.
